In pursuit of new anticancer drugs, scientists aboard a recent Fiji Aggressor II live-aboard dive charter from the University of the South Pacific, working in conjunction with scientists from the University of Utah sampled marine invertebrate tissues from around Vanua Levu. These will be tested initially in Fiji and then in the United States to see if they have potential to kill cancer cells. Marine invertebrates, especially those that cannot move, often use poisonous chemicals to protect themselves. Several promising leads have been found from such research in Fiji over the last decade, especially samples from two Beqa Lagoon orange sponges. The research is funded by a United States National Cancer Drug Discovery grant. Another important aspect of the work is the conservation of these marine resources; divers monitor the health of the coral reefs and discuss their findings with nearby communities.
The Fiji Aggressor II is a 101-foot, 10-passenger dive live-aboard. For more information, call 800-348-2628 or visit www.sportdiver.com/ebrochure/aggressor.
ALREADY A MEMBER?
Find exclusive opportunities and packages offered to Society members on the member benefits site.
Join the PADI Diving Society and take advantage of over $99,500 in savings and incentives! 1 year subscription to Sport Diver magazine, including the World's Best Diving & Resorts Special Issue


